Palleon Pharma

Pioneering next-generation autoimmune and cancer medicines through glycobiology

Waltham, United States · Founded 2016 · $147.6M raised

Employees
11–50
Founded
2016
Business Model
B2B
Total Funding
$147.6M
Last Round
$100.0M Series BSep 2020
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 7 investors for this company. The full record is or through the API.

About

Palleon Pharmaceuticals is a clinical-stage biotechnology company pioneering a new class of medicines — glycoimmune checkpoint inhibitors — that target the Siglec/sialoglycan axis to treat cancer and autoimmune diseases. The company was co-founded by Nobel laureate Dr. Carolyn Bertozzi (Stanford) and glycoimmunology pioneer Dr. Paul Crocker (University of Dundee) alongside CEO Jim Broderick, an experienced biotech entrepreneur. Palleon's proprietary platforms (EAGLE, CONVERGENCE, and HYDRA) represent a novel biological layer distinct from existing PD-1/CTLA-4 checkpoint therapies, addressing tumors and autoimmune conditions where current treatments have failed. The company has raised $147 million since inception and is headquartered in Waltham, Massachusetts.

Summary

Palleon Pharma is a Biotech company based in Waltham, United States, founded in 2016. It has raised $147.6M in total across 2 rounds, most recently a $100.0M Series B round in Sep 2020. Investors include Matrix Capital Management, SR One and Pfizer Ventures.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BSep 2020
$100.0M

Sign up to see all 2 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Palleon Pharma on Indexed.vc
<a href="https://indexed.vc/companies/palleon-pharma"><img src="https://indexed.vc/api/badge/company/palleon-pharma" alt="Palleon Pharma on Indexed.vc" width="260" height="76" /></a>